Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Expert Opinion on Emerging Drugs
|
November 6, 2007
Monoclonal antibodies for prophylaxis and therapy of infectious diseases
Jan ter Meulen
Infectious Disease Clinics of North America
|
November 8, 2011
Monoclonal antibodies in infectious diseases: clinical pipeline in 2011
Jan Ter Meulen
Nature Biotechnology
|
September 11, 2010
Pushing the envelope on HIV-1 neutralization
Joseph G Joyce, Jan ter Meulen
Human Vaccines & Immunotherapeutics
|
November 22, 2016
Immune Design
Jan Ter Meulen, Stephen R Brady
The Journal of General Virology
|
July 12, 2007
Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity
Christian Klewitz, Hans-Dieter Klenk, Jan Ter Meulen
Expert Review of Vaccines
|
April 6, 2007
Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development
Mark Throsby, Jan Ter Meulen, Cecile Geuijen, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
February 2, 2008
Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence in Guinea, West Africa
Elisabeth Fichet-Calvet, Emilie Lecompte, Lamine Koivogui, et al.
Travel Medicine and Infectious Disease
|
February 15, 2007
The potential of targeted antibody prophylaxis in SARS outbreak control: a mathematic analysis
Johannes Antonie Bogaards, Hein Putter, Gerrit Jan Weverling, et al.
Plos One
|
May 23, 2012
The impact of human conflict on the genetics of Mastomys natalensis and Lassa virus in West Africa
Aude Lalis, Raphaël Leblois, Emilie Lecompte, et al.
Microbial Biotechnology
|
November 23, 2011
Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates
I-Ming Wang, Andrew J Bett, Razvan Cristescu, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Expert Opinion on Emerging Drugs
|
November 6, 2007
Monoclonal antibodies for prophylaxis and therapy of infectious diseases
Jan ter Meulen
Infectious Disease Clinics of North America
|
November 8, 2011
Monoclonal antibodies in infectious diseases: clinical pipeline in 2011
Jan Ter Meulen
Nature Biotechnology
|
September 11, 2010
Pushing the envelope on HIV-1 neutralization
Joseph G Joyce, Jan ter Meulen
Human Vaccines & Immunotherapeutics
|
November 22, 2016
Immune Design
Jan Ter Meulen, Stephen R Brady
The Journal of General Virology
|
July 12, 2007
Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity
Christian Klewitz, Hans-Dieter Klenk, Jan Ter Meulen
Expert Review of Vaccines
|
April 6, 2007
Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development
Mark Throsby, Jan Ter Meulen, Cecile Geuijen, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
February 2, 2008
Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence in Guinea, West Africa
Elisabeth Fichet-Calvet, Emilie Lecompte, Lamine Koivogui, et al.
Travel Medicine and Infectious Disease
|
February 15, 2007
The potential of targeted antibody prophylaxis in SARS outbreak control: a mathematic analysis
Johannes Antonie Bogaards, Hein Putter, Gerrit Jan Weverling, et al.
Plos One
|
May 23, 2012
The impact of human conflict on the genetics of Mastomys natalensis and Lassa virus in West Africa
Aude Lalis, Raphaël Leblois, Emilie Lecompte, et al.
Microbial Biotechnology
|
November 23, 2011
Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates
I-Ming Wang, Andrew J Bett, Razvan Cristescu, et al.
Page
of 6